Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAOA | P21397 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL497005 | 0.87 | MEN1 (0.61) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL29883673 | 0.87 | MEN1 (0.61) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL2639287 | 0.79 | NQO1 (0.60) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL2908244 | 0.79 | MEN1 (0.47) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL31218584 | 0.77 | KDM4E (0.61) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL375358 | 0.77 | KDM4E (0.61) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL29612818 | 0.77 | KDM4E (0.61) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL11716746 | 0.77 | DAPK1 (0.58) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL11141991 | 0.77 | MEN1 (0.55) | MAPTKMT2AKDM4EMEN1TDP1 | |
| SCHEMBL31171154 | 0.77 | MAPT (0.54) | MAPTKMT2AKDM4EMEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439407-B2 | Fluorinated pentacene derivative and method of producing same | KANTO DENTA KOGYO CO., LTD. (JP) | 2008-10-21 | — | — | US | disclosed |
| US-7439407-B2 | Fluorinated pentacene derivative and method of producing same | KANTO DENTA KOGYO CO., LTD. (JP) | 2008-10-21 | — | — | US | disclosed |
| US-7439407-B2 | Fluorinated pentacene derivative and method of producing same | KANTO DENTA KOGYO CO., LTD. (JP) | 2008-10-21 | — | — | US | disclosed |
| US-20070083067-A1 | Fluorinated pentacene derivative and method of producing same | KANTO DENKA KOGYO CO. LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20070083067-A1 | Fluorinated pentacene derivative and method of producing same | KANTO DENKA KOGYO CO. LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20070083067-A1 | Fluorinated pentacene derivative and method of producing same | KANTO DENKA KOGYO CO. LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070083067-A1 | Fluorinated pentacene derivative and method of producing same | FAR1, FAM162A, FFAR4 | MAPT 4726/4885KMT2A 4146/4885KDM4E 3554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.